Skip to main content
TipRanks
Go Ultimate75% OFF

Schond L. Greenway Insider Profile

4 Followers

Schond L. Greenway, CFO at Avalo Therapeutics, holds 3.88K shares in Avalo Therapeutics (Ticker: AVTX).

Schond L. Greenway's Trading History

AVTX
Avalo Therapeutics
Dec 14, 2021CFOUninformative Buy3.50K$28.62K
AVTX
Insider Shares: 3.88K (<0.01%)

Schond L. Greenway has not reported any informative transactions for AVTX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 14, 2021Uninformative Buy$3.50K2,231$1.57―
Jun 14, 2021Uninformative Buy$1.75K652$2.68―

You May Also Like

Schond L. Greenway insider profile FAQ

What stocks does Schond L. Greenway hold?
Schond L. Greenway holds: AVTX stocks.
What was Schond L. Greenway’s latest transaction?
Schond L. Greenway’s latest transaction was an Uninformative Buy of $3.50K.
What is Schond L. Greenway's role in Avalo Therapeutics?
Schond L. Greenway's role in Avalo Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.